HSPB1 and myopathy: Skeletal muscle targeting by HSPB1 is not surprising since HSPB1 mutations (e.g., D129E and R140G) have been described in patients showing myopathy features (Lewis-Smith et al., 2016; Bugiardini et al., 2017).